Therapeutic induction of tertiary lymphoid structures (TLS) by locoregional hetIL-15 drives durable anti-tumor immunity in murine breast cancer models (SITC 2026) - Oct 2, 2026 - Abstract #812; Pres time: Nov 7, 2026; No abstract available
Preclinical • Breast Cancer • Oncology • Solid Tumor
|
|
Dimitrios Stellas; Sevasti Karaliota; Laura Basel; Katherine Goldfarbmuren; George Pavlakis; Barbara Felber
|